Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
15-Sep-2026 | 780.25 | 792 | 762.15 | 765.65 | 26,631 | 26,83,52,832.65 | 1,69,964 |
16-Sep-2026 | 759.2 | 775 | 746.4 | 772 | 13,214 | 18,03,03,375.7 | 1,25,128 |
17-Sep-2026 | 768.1 | 789.35 | 763.9 | 766.7 | 13,506 | 16,68,77,645.8 | 1,20,626 |
18-Sep-2026 | 767.1 | 790 | 767.1 | 783.7 | 24,523 | 25,73,85,129.15 | 2,03,792 |
21-Sep-2026 | 785 | 830 | 779.7 | 821.45 | 39,953 | 67,58,20,516.25 | 3,06,314 |
22-Sep-2026 | 830 | 834.7 | 801 | 807.9 | 14,426 | 21,41,52,383.5 | 1,33,989 |
23-Sep-2026 | 810 | 838.8 | 810 | 823.3 | 27,853 | 35,95,18,605.65 | 2,24,946 |
24-Sep-2026 | 824 | 836.8 | 813.3 | 817.6 | 14,484 | 18,04,79,934.95 | 1,27,049 |
25-Sep-2026 | 817 | 828.65 | 811 | 819.55 | 11,530 | 12,54,54,803.5 | 76,783 |
28-Sep-2026 | 819.55 | 825 | 798 | 799.95 | 11,397 | 12,67,97,428.2 | 75,881 |
29-Sep-2026 | 800 | 828 | 800 | 819.55 | 17,695 | 14,62,88,086.5 | 88,812 |
30-Sep-2026 | 828.2 | 828.2 | 811.1 | 818.5 | 15,646 | 16,11,42,528.75 | 1,03,927 |
01-Oct-2026 | 815 | 828.2 | 802.2 | 813.1 | 15,063 | 15,60,82,032.1 | 85,851 |
05-Oct-2026 | 819 | 825 | 796.35 | 801.35 | 9,967 | 9,44,53,573.8 | 52,310 |
06-Oct-2026 | 802 | 818 | 796.3 | 814.65 | 8,106 | 10,41,21,110.45 | 71,715 |
07-Oct-2026 | 819.8 | 833 | 814.65 | 822.55 | 11,753 | 12,69,20,148.4 | 69,263 |
08-Oct-2026 | 816.6 | 831.95 | 773.2 | 786.7 | 28,526 | 23,91,79,908.05 | 1,36,010 |
09-Oct-2026 | 780.8 | 791.9 | 740.8 | 751.85 | 33,985 | 33,33,75,715.25 | 1,94,814 |
The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.
The IPO comprised a fresh issue of shares worth ₹680 crore and an offer-for-sale (OFS) of 1.73 crore shares, aggregating ₹1,177 crore.
The IPO consists of a fresh issue of ₹680 crore and an offer for sale (OFS) of up to 1.73 crore shares at a face value of ₹2 each.
On Monday, the business said that it had received ₹829 crore from anchor investors ahead of the public share sale subscription period.
The IPO includes a new issue of 1 Crore shares worth ₹680.00 Crore and an offer for sale of 1.73 Crore shares worth ₹1,176.74 Crore.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
